Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Inks Blue Cross Contract for PGx Cardiac Test

NEW YORK (GenomeWeb News) – Clinical Data has signed an agreement with the Blue Cross and Blue Shield Association to offer its genetic tests for inherited cardiac syndromes to BCBSA member companies.

The agreement will give BCBSA's 39 member companies access to the Familion Long QT Syndrome test, which is offered through Clinical Data's PGxHealth division. The individual insurers will be able to independently enter into an ancillary contract to offer the tests to their members.

The Familion group of tests detect mutations that can cause cardiac channelopathies or cardiomyopathies, such as Long QT Syndrome; Brugada Syndrome; Catecholaminergic Polymorphic Ventricular Tachycardia; Hypertrophic Cardiomyopathy; and Arrhythmogenic Right Ventricular Cardiomyopathy

Clinical Data said that nearly 200 million patients in the US are now covered by providers and private payers who offer access to the firm's genetic tests.

Filed under

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.